Volume 119, Issue 5, Pages (November 2000)

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 1999)
Advertisements

Volume 114, Issue 5, Pages (May 1998)
Volume 57, Issue 3, Pages (March 2000)
Genetic Inactivation of RelA/p65 Sensitizes Adult Mouse Hepatocytes to TNF-induced Apoptosis In Vivo and In Vitro  Fabian Geisler, Hana Algül, Stephan.
Volume 126, Issue 1, Pages (January 2004)
Volume 118, Issue 4, Pages (April 2000)
Volume 57, Issue 3, Pages (March 2000)
Genetic Inactivation of RelA/p65 Sensitizes Adult Mouse Hepatocytes to TNF-induced Apoptosis In Vivo and In Vitro  Fabian Geisler, Hana Algül, Stephan.
Volume 124, Issue 5, Pages (May 2003)
Signal transduction pathways triggered by the FcϵRIIb receptor (CD23) in human monocytes lead to nuclear factor-κB activation  Rosa M. Ten, MD, PhDa,
Volume 129, Issue 3, Pages (September 2005)
Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes  N. Chabane, M.Sc.,
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing.
Volume 114, Issue 4, Pages (April 1998)
Volume 126, Issue 1, Pages (January 2004)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Estela Jacinto, Guy Werlen, Michael Karin  Immunity 
Volume 30, Issue 3, Pages (March 2009)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 56, Issue 5, Pages (November 1999)
Α-MSH inhibits TNF-α-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor κB signaling in human chondrosarcoma HTB-94.
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
A Mechanism for Inhibiting the SUMO Pathway
High Mobility Group Protein I(Y) Is Required for Function and for c-Rel Binding to CD28 Response Elements within the GM-CSF and IL-2 Promoters  S.Roy.
Angiotensin II-induced growth of vascular smooth muscle cells requires an Src- dependent activation of the epidermal growth factor receptor1  Dirk Bokemeyer,
Volume 56, Issue 4, Pages (October 1999)
Volume 120, Issue 5, Pages (April 2001)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Identification and Characterization of an IκB Kinase
HDAC Activity Is Required for p65/RelA-Dependent Repression of PPARδ-Mediated Transactivation in Human Keratinocytes  Lene Aarenstrup, Esben Noerregaard.
Volume 119, Issue 2, Pages (August 2000)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 129, Issue 5, Pages (November 2005)
Volume 115, Issue 5, Pages (November 2003)
Neurotensin receptor–1 and –3 complex modulates the cellular signaling of neurotensin in the HT29 cell line  Stéphane Martin, Valérie Navarro, Jean Pierre.
Volume 93, Issue 5, Pages (May 1998)
Volume 119, Issue 1, Pages (July 2000)
Lisheng Ge, Ziqiu Wang, Meifang Wang, Siddhartha Kar, Brian I. Carr 
Histamine Enhances the Production of Granulocyte-Macrophage Colony-Stimulating Factor via Protein Kinase Cα and Extracellular Signal-Regulated Kinase.
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431 
Volume 128, Issue 1, Pages (January 2005)
Ketoconazole Suppresses Prostaglandin E2-Induced Cyclooxygenase-2 Expression in Human Epidermoid Carcinoma A-431 Cells  Naoko Kanda, Dr., Shinichi Watanabe 
Volume 11, Issue 6, Pages (June 2003)
17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
Interleukin-6-Resistant Melanoma Cells Exhibit Reduced Activation of STAT3 and Lack of Inhibition of Cyclin E-Associated Kinase Activity  Markus Böhm,
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 61, Issue 6, Pages (June 2002)
Volume 116, Issue 6, Pages (June 1999)
Lori Wilson, Csaba Szabó, Andrew L. Salzman  Gastroenterology 
Volume 126, Issue 4, Pages (April 2004)
Volume 119, Issue 1, Pages (July 2000)
Volume 123, Issue 6, Pages (December 2002)
Volume 6, Issue 4, Pages (October 2000)
Volume 96, Issue 6, Pages (March 1999)
Volume 122, Issue 1, Pages (January 2002)
NF-κB/Rel/IκB: Implications in gastrointestinal diseases
Volume 125, Issue 4, Pages (May 2006)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
1α,25-Dihydroxyvitamin D3 Stimulates Activator Protein 1 DNA-Binding Activity by a Phosphatidylinositol 3-Kinase/Ras/MEK/Extracellular Signal Regulated.
Angiotensin III increases MCP-1 and activates NF-кB and AP-1 in cultured mesangial and mononuclear cells  Marta Ruiz-Ortega, Oscar Lorenzo, Jesus Egido 
Thiocolchicoside inhibits TNF-dependent IκBα phosphorylation, IκBα degradation, p65 phosphorylation, and p65 nuclear translocation. Thiocolchicoside inhibits.
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 61, Issue 6, Pages (June 2002)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Heterozygous N-terminal deletion of IκBα results in functional nuclear factor κB haploinsufficiency, ectodermal dysplasia, and immune deficiency  Douglas.
Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Volume 129, Issue 5, Pages (June 2007)
Volume 10, Issue 2, Pages (February 1999)
Presentation transcript:

Volume 119, Issue 5, Pages 1209-1218 (November 2000) Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β  Christoph K. Weber, Susanne Liptay, Thomas Wirth, Guido Adler, Roland M. Schmid  Gastroenterology  Volume 119, Issue 5, Pages 1209-1218 (November 2000) DOI: 10.1053/gast.2000.19458 Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 1 Sulfasalazine inhibits nuclear NF-κB/Rel and transcriptional activity induced by TNF-α or TPA. (A) Electromobility shift assay showing inhibition of TNF-α–induced NF-κB/Rel binding activity by sulfasalazine. Jurkat T cells were left untreated (lane 1) or stimulated with TNF-α (150 U/mL for 30 minutes) (lanes 2–6). Cells were pretreated for 1 or 3 hours with 2 mmol/L sulfasalazine before stimulation with TNF-α (lanes 3 and 4). Binding specificity was confirmed by incubation with a 100-fold of an unrelated oligonucleotide spanning an Sp1 binding site (lane 6). The arrows indicate the position of the κB-specific DNA binding activity and the position of a nonspecific (n.s.) activity. (B) Jurkat T cells or (C and D) SW620 colon cells were transfected with a κB-dependent reporter construct (3×IgκBLuc). After 18 hours, cultures were treated with sulfasalazine (0.1, 1, or 2 mmol/L) 30 minutes before stimulation with (B and C) 150 U/mL TNF-α or (D) 10 ng/mL TPA. Extracts were prepared after an additional 18 hours and assayed for luciferase activity. Luciferase activity obtained without adding sulfasalazine was set to 100%. Values are expressed as means ± SEM of at least 3 independent experiments performed in duplicate. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 2 Sulfasalazine inhibits NIK-induced κB-dependent transcription. Jurkat T cells (■) and SW620 colon cells (▩) were transfected with 3×IgκBLuc and 200 ng of a NIK expression vector and incubated after 18 hours with either medium alone (co) or with sulfasalazine (SS), 5-ASA, 4-ASA, or sulfapyridine (SP) at 2 mmol/L. After another 18 hours, luciferase activity was determined. Values are expressed as means ± SEM of at least 3 independent experiments performed in duplicate. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 3 Sulfasalazine, but not 4-ASA, 5-ASA, or sulfapyridine, blocks IKK-α– and IKK-β–induced NF-κB/Rel–dependent transcription. (A) Jurkat T cells were transfected with a reporter construct (3×IgκBLuc) together with an empty expression vector or increasing amounts of an HA-IKK-α expression vector as indicated. (B) Jurkat T cells were similarly transfected with an HA-IKK-β expression vector. (C) For inhibition experiments, Jurkat T cells (■) or SW620 cells (▩) were transfected with 3×IgκBLuc and 5 mg of HA-IKK-α expression vector and incubated for 18 hours with either medium alone (co) or with sulfasalazine (SS), 5-ASA, 4-ASA, or sulfapyridine (SP) for another 18 hours. (D) In a similar experiment, cells were transfected with the 3×lgκBLuc reporter construct and 5 mg of HA-IKK-β expression vector and treated after 18 hours as indicated. After another 18 hours, luciferase activity was determined. Values are expressed as means ± SEM of at least 3 independent experiments performed in duplicate. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 4 Sulfasalazine, but not 4-ASA, 5-ASA, or sulfapyridine, inhibits endogenous IKK activity. (A–C) SW620 cells or (D–F) Jurkat T cells were treated for 30 minutes with medium alone, sulfasalazine (0.5, 1, or 2 mmol/L), sulfapyridine (2 mmol/L), 5-ASA (2 mmol/L), or 4-ASA (2 mmol/L) before stimulation with TNF-α, 150 U/mL for 30 minutes. (A and D) IKK-α and IKK-β were immunopurified from cell extracts, and kinase activity was determined using GST-IκBα (1-54) as substrate. (B and E) Immunoprecipitates were analyzed by Western blotting using an IKK antibody recognizing IKK-α and IKK-β. (C and F) Kinase activity was quantitated using a phosphorimager and plotted as percent activity. Findings are representative of 3 independent experiments. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 5 Sulfasalazine does not inhibit TNF-α–induced phosphorylation of Erk1/2, JNK1, or p38. As indicated, SW620 colonic cells were pretreated with medium containing 2 mmol/L sulfasalazine for 30 minutes, then stimulated with TNF-α (150 U/mL for 10 minutes) or left untreated. Activated (A) Erk1/2, (B) JNK1, or (C) p38 was detected by Western blotting using phospho-specific antibodies (upper panel). To determine the total amount of kinases, membranes were stripped and reprobed with antibodies against wild-type kinases. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 6 Sulfasalazine inhibits activity and autophosphorylation of purified IKK-α and IKK-β in vitro. Recombinant (A) IKK-α and (B) IKK-β were incubated with DMSO (control) or the indicated concentrations of sulfasalazine in the presence of [γ-32P]ATP and GST-IκBα (1-54) for 30 minutes. Proteins were separated by SDS-PAGE. The upper panel shows representative autoradiographs of (A) IKK-α and (B) IKK-β autophosphorylation as well as substrate phosphorylation. *GST-IκBα bands were quantitated and plotted (lower panel). Values are expressed as means ± SEM of at least 3 independent experiments. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 7 Sulfasalazine, but not 5-ASA, sulfapyridine, or aspirin, inhibits IKK-α/IKK-β activity. Recombinant (A) IKK-α and (B) IKK-β were incubated with DMSO, sulfasalazine, 5-ASA, sulfapyridine, or aspirin at 1 mmol/L in the presence of [γ-32P]ATP and GST-IκBα (1-54) for 30 minutes. Thereafter, proteins were separated by SDS-PAGE (upper panel). GST-IκBα bands were cut out, and activity was determined in a scintillation counter (lower panel). Values are expressed as means ± SEM of at least 3 independent experiments. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 8 Sulfasalazine-mediated inhibition of IKK-α and IKK-β activity is blocked by increasing the ATP concentration. Recombinant (A) IKK-α and (B) IKK-β were incubated with the indicated concentrations of sulfasalazine and ATP. Kinase reaction was initiated by adding recombinant GST-IκBα (1-54) as substrate. Parallel kinase reactions were performed without the inhibitor. After 30 minutes, kinase reactions were stopped and proteins were separated by SDS-PAGE. GST-IκBα (1-54) bands were cut out, and activity was determined in a scintillation counter. Values obtained from kinase reactions with sulfasalazine without the addition of ATP were set to 100%. Inhibition of IKK activity by sulfasalazine is expressed as the mean ± SEM of at least 3 independent experiments. Gastroenterology 2000 119, 1209-1218DOI: (10.1053/gast.2000.19458) Copyright © 2000 American Gastroenterological Association Terms and Conditions